FDA Inspection 1274304 — Astellas Pharma Inc.
The FDA completed an inspection of Astellas Pharma Inc. on June 6, 2025 in Takahagi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 6, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Takahagi (Japan)